Recent Transactions

08-Jun-25
Pending
Undisclosed
Target: 

Pinnacle Towers / KKR

Canada flag
Acquiror: 
BCI

Sole financial advisor to KKR on British Columbia Investment Management Corporation’s (“BCI”) investment into Pinnacle Towers, the largest independent TowerCo in the Philippines

11-Feb-25
$320 million (AUD value)
Australia flag
Target: 

Pacific Smiles Group

Australia flag
Acquiror: 
Genesis Capital

Advised Pacific Smiles Group Limited, one of Australia’s leading and fastest growing dental service organisations, on its response to multiple private equity proposals and ultimate sale to Genesis Capital by way of off-market takeover

14-Jan-25
Pending
$166.5 million (AUD value)
Australia flag
Target: 

Bullabulling Gold Project

Australia flag
Acquiror: 
Minerals 260

Advising Minerals 260 on its purchase of the Bullabulling Gold Project from Norton Gold Fields (a wholly-owned subsidiary of one of the world’s largest gold producers, Zijin Mining Group)

24-Dec-24
Undisclosed
Israel flag
Target: 

Ex-US rights to branded narcolepsy treatments, Provigil® (modafinil) and Nuvigil® (armodafinil)

Germany flag
Acquiror: 
Neuraxpharm Group

Advised Neuraxpharm Group (“Neuraxpharm”), a leading European specialty pharmaceutical company, on the acquisition of the ex-US rights to Provigil® (modafinil) and Nuvigil® (armodafinil) from Teva Pharmaceuticals Industries Ltd. (“Teva”)

13-Nov-24
Pending
Undisclosed
Germany flag
Target: 

Centogene GmbH

Italy flag
Acquiror: 
Charme Capital Partners

Advising Charme Capital Partners, a European mid-market private equity fund, on the acquisition of Centogene GmbH, a leading provider of  pharmaceutical solutions and diagnostic tests for rare diseases

28-Oct-24
$1.8 billion (CAD value)
Canada flag
Target: 

Xplore Inc.

flag not available

Advised the Ad Hoc Crossover Group to Xplore on its CBCA Restructuring of C$1.8 billion of Secured Debt

30-Sep-24
Undisclosed
United States flag
Target: 

Golub Capital LLC

Japan flag
Acquiror: 
Mizuho Bank, Ltd.

Advising Mizuho Bank, Ltd., the banking arm of Mizuho Financial Group, Inc., on its purchase of a passive, non-voting minority stake in Golub Capital’s management companies

19-Sep-24
$550 million
Canada flag
Target: 

Tacora Resources, Inc.

United States flag
Acquiror: 
O’Brien-Staley Partners, Millstreet Capital Management LLC, Brigade Capital Management LP, Cargill Incorporated

Advised Tacora Resources, a high-grade iron ore producer in Canada, on its CCAA Sale Process and Restructuring of $550 million of liabilities

02-Jul-24
$250 million
Australia flag
Target: 

Liontown Resources Limited

Korea flag
Acquiror: 
LG Energy Solution

Advised Liontown Resources on its strategic partnership and convertible note funding with LG Energy Solution

06-May-24
Pending
Undisclosed
Netherlands flag
Target: 

Veen Bosch & Keuning

United States flag
Acquiror: 
Simon & Schuster

Advising Veen Bosch & Keuning, the largest book publisher in the Netherlands, on its sale to Simon & Schuster, one of the world’s preeminent publishing houses 

05-Apr-24
$820 million (AUD)
Australia flag
Target: 

illion Australia Pty Ltd

United Kingdom flag
Acquiror: 
Experian Plc

Advising Experian Plc, the world’s leading global information services company, on the acquisition of  illion Australia Pty Ltd, one of Australasia's leading consumer and commercial credit bureaus

13-Mar-24
$590 million (AUD value)
Australia flag
Target: 

Liontown Resources Limited

flag not available

Advised Australian-based lithium company Liontown Resources Limited on its A$590m debt facility to fund the Kathleen Valley Lithium Project

20-Feb-24
Pending
$185 million
Australia flag
Target: 

myHomecare Group

Australia flag
Acquiror: 
Australian Unity

Advising Australian Unity on its acquisition of myHomecare Group

21-Dec-23
Undisclosed
Australia flag
Target: 

Exit of Homesafe Equity Release Joint Venture

Australia flag
Acquiror: 
Athy Pty Ltd

Adviser to Bendigo and Adelaide Bank on the exit of its investment in the Homesafe Equity Release Joint Venture

19-Oct-23
$390 million (AUD value)
Australia flag
Target: 

Liontown Resources Limited

flag not available

Advised Australian-based lithium company Liontown Resources Limited on its A$390m equity raising to fund the Kathleen Valley Lithium Project

04-Sep-23
Pending
$6.6 billion AUD
Australia flag
Target: 

Liontown Resources Limited

United States flag
Acquiror: 
Albemarle Corporation

Advising Australian-based lithium company Liontown Resources Limited on its response to change of control proposals from Albemarle Corporation

08-Aug-23
Pending
Undisclosed
Spain flag
Target: 

Farmalider Group

Spain flag
Acquiror: 
MCH

Advising the shareholders of Grupo Farmalider, a B2B Spanish pharmaceutical company focused on contract manufacturing, innovation and development of products based on generics, on the sale of an undisclosed stake to local private equity MCH

21-Jul-23
Undisclosed
France flag
Target: 

Synfonium / Qwant / Shadow

France flag
Acquiror: 
Caisse des Dépôts et Consignations (CDC) / Banque des Territoires

Advised Banque des Territoires / Groupe Caisse des Dépôts (CDC), a French Public Institution, on the investment in the newly created platform Synfonium, incorporating Shadow, a cloud-based platform, and Qwant, a sovereign search engine. CDC will hold a 25% stake in Synfonium, while Octave Klaba and Miroslaw Klaba, the co-founders of OVHcloud, will hold the remaining 75%

25-Apr-23
Pending
Undisclosed
United Kingdom flag
Target: 

Kyowa Kirin International’s testosterone replacement therapy drug, Tostran®

United Kingdom flag
Acquiror: 
Advanz Pharma (UK)

Advising Kyowa Kirin International, a subsidiary of Kyowa Kirin Co., Ltd, a Japanese global specialty pharma company, on the divestiture of its testosterone replacement therapy drug, Tostran®, to Advanz Pharma, a privately-held, specialty pharmaceutical company

20-Mar-23
Pending
Undisclosed
Target: 

Clinigen Ltd’s Lamda Laboratories

Germany flag
Acquiror: 
Adragos Pharma

Advising Clinigen Ltd, a UK-based global pharmaceutical services company and portfolio company of Triton Partners, on the sale of Lamda Laboratories, a European contract development business, to Adragos Pharma, a Munich-based pharmaceutical CDMO

30-Dec-22
$153 million
United States flag
Target: 

Annovera®, Imvexxy®, Bijuva®, and prescription prenatal vitamin products

Australia flag
Acquiror: 
Mayne Pharma

Advised TherapeuticsMD, Inc., an innovative, leading women’s healthcare company on definitive agreements to license its products to Mayne Pharma

28-Dec-22
Pending
Undisclosed
Japan flag
Target: 

Eisai Distribution Co., Ltd.

Japan flag
Acquiror: 
Yasuda Logistics Corporation

Advising Eisai, a Japanese pharmaceutical company, on the sale of Eisai Distribution, a 100% shares holding logistic subsidiary, to Yasuda Logistics Corporation, a Japanese logistic company conducting total logistic services such as Warehousing, Transportation, delivery and forwarding, and Port transportation business, etc.

24-Nov-22
Pending
Undisclosed
Target: 

Kyowa Kirin International’s established medicines business

Germany flag
Acquiror: 
Grünenthal

Advising Kyowa Kirin International, a subsidiary of Kyowa Kirin Co., Ltd, a Japanese global specialty pharma company, on a collaboration agreement with Grünenthal GmbH, a global, science-based, privately-owned pharmaceutical company

18-Nov-22
Pending
$6.4 billion
Australia flag
Target: 

OZ Minerals Limited

Australia flag
Acquiror: 
BHP Group Limited

Advising Australian-based copper company OZ Minerals Limited, on its response to two change of control proposals from BHP Group Limited, the world’s largest diversified resources company

22-Aug-22
Pending
$92.9 million
Australia flag
Target: 

Australian Executor Trustees

Australia flag
Acquiror: 
Equity Trustees

Advising Equity Trustees, one of Australia’s leading specialist trustee companies, on the acquisition of Australian Executor Trustees from Insignia Financial

Pages

show all